Comparison between Aster Silicates IPO and Parabolic Drugs IPO.
Aster Silicates IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Parabolic Drugs IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Aster Silicates IPO is up to ₹53.10 Cr whereas the issue size of the Parabolic Drugs IPO is up to ₹200.00 Cr. The final issue price of Aster Silicates IPO is ₹118.00 per share and of Parabolic Drugs IPO is ₹75.00 per share.
| Aster Silicates IPO | Parabolic Drugs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹112.00 per share | ₹75.00 per share |
| Issue Price (Upper) | ₹118.00 per share | ₹85.00 per share |
| Issue Price (Final) | ₹118.00 per share | ₹75.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 50 shares | 80 shares |
| Fresh Issue Size | 45,00,000 shares | 2,46,40,965 shares |
| Fresh Issue Size (Amount) | up to ₹53.10 Cr | up to ₹184.81 Cr |
| OFS Issue Size | 0 shares | 20,25,702 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹15.19 Cr |
| Issue Size Total | 45,00,000 shares | 2,66,66,667 shares |
| Issue Size Total (Amount) | up to ₹53.10 Cr | up to ₹200.00 Cr |
Aster Silicates IPO opens on Jun 24, 2010, while Parabolic Drugs IPO opens on Jun 14, 2010. The closing date of Aster Silicates IPO and Parabolic Drugs IPO is Jun 28, 2010, and Jun 17, 2010, respectively.
| Aster Silicates IPO | Parabolic Drugs IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jun 24, 2010 | Jun 14, 2010 |
| Issue Close | Jun 28, 2010 | Jun 17, 2010 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Jul 28, 2010 | Jul 01, 2010 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Aster Silicates IPO P/E ratio is , as compared to Parabolic Drugs IPO P/E ratio of .
| Aster Silicates IPO | Parabolic Drugs IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 71.43 | 63.21 | ||||
| Promoter Shareholding (Post-Issue) | 49.8 | 38.04 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹175.36 Cr. | ₹464.19 Cr. | ||||
| ROE | ||||||
| ROCE | 16.36 | 6.21 | ||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 14.18 | 19.96 |
In the Aster Silicates IPO Retail Individual Investors (RII) are offered 15,75,000 shares while in Parabolic Drugs IPO retail investors are offered 15,75,000 shares. Qualified Institutional Buyers (QIB) are offered 22,50,000 shares in Aster Silicates IPO and 1,30,83,333 shares in Parabolic Drugs IPO.
| Aster Silicates IPO | Parabolic Drugs IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 22,50,000 shares | 1,30,83,333 shares |
| NII | 6,75,000 shares | 39,25,000 shares |
| RII | 15,75,000 shares | 91,58,334 shares |
| Employee | 5,00,000 shares | |
| Others | ||
| Total | 45,00,000 shares | 2,66,66,667 shares |
Aster Silicates IPO subscribed 4.71x in total, whereas Parabolic Drugs IPO subscribed 1.04x.
| Aster Silicates IPO | Parabolic Drugs IPO | |
|---|---|---|
| QIB (times) | 0.01x | 1.48x |
| NII (times) | 13.13x | 1.20x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 7.81x | 0.40x |
| Employee (times) | 0.11x | |
| Other (times) | ||
| Total (times) | 4.71x | 1.04x |
